DeepMed Research

UNIVERSITY OF ROCHESTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-01-01

Employees: 10K

Market Cap: -

Website: http://www.rochester.edu

Clinical Trials

A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes

Phase 1

Completed

Conditions: Chronic Myelomonocytic Leukemia
Myelodysplastic Syndromes

Interventions: Drug: abaloparatide
Drug: bevacizumab

First Posted Date: 2018-11-19

Last Posted Date: 2023-01-23

Lead Sponsor: University of Rochester

Target Recruit Count: 20

Registration Number: NCT03746041

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

Phase 2

Recruiting

Conditions: Hodgkin Disease
All
Myelodysplastic Syndrome
AML
NHL

Interventions: Drug: Hyperbaric oxygen

First Posted Date: 2018-11-13

Last Posted Date: 2024-08-19

Lead Sponsor: University of Rochester

Target Recruit Count: 64

Registration Number: NCT03739502

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Not Applicable

Recruiting

Conditions: Lung Cancer

Interventions: Device: radiation therapy-3 fractions
Device: Radiation therapy-5 fractions

First Posted Date: 2018-10-15

Last Posted Date: 2025-04-24

Lead Sponsor: University of Rochester

Target Recruit Count: 100

Registration Number: NCT03706027

Locations: 🇺🇸
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York, United States

Acceptability of Palliative Care in Parkinson Disease Care

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Palliative Care referral

First Posted Date: 2018-10-05

Last Posted Date: 2019-12-09

Lead Sponsor: University of Rochester

Target Recruit Count: 20

Registration Number: NCT03697434

Locations: 🇺🇸
URMC Neurology; 919 Westfall Rd, Building C, Rochester, New York, United States

Pilot Randomized Trial With Flecainide in ARVC Patients

Phase 2

Completed

Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy

Interventions: Drug: Flecainide Pill
Drug: Placebo

First Posted Date: 2018-09-26

Last Posted Date: 2024-08-20

Lead Sponsor: University of Rochester

Target Recruit Count: 22

Registration Number: NCT03685149

Locations: 🇺🇸
John Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Pensylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Colorado, Denver, Colorado, United States

and more 3 locations

Wearable Assessments in the Clinic and Home in PD

Completed

Conditions: Parkinson Disease

First Posted Date: 2018-09-21

Last Posted Date: 2024-10-07

Lead Sponsor: University of Rochester

Target Recruit Count: 132

Registration Number: NCT03681015

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Sentara Clinical Research, Virginia Beach, Virginia, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

and more 14 locations

Hearing Study: Sensitivity to Features of Speech Sounds

Not Applicable

Recruiting

Conditions: Hearing Loss, Sensorineural

Interventions: Other: Signal processing to improve intelligibility

First Posted Date: 2018-09-12

Last Posted Date: 2023-11-28

Lead Sponsor: University of Rochester

Target Recruit Count: 200

Registration Number: NCT03666676

Locations: 🇺🇸
University of Rochester, Rochester, New York, United States

Duration of Effect of Biotene Spray in Patients With Dry Mouth

Not Applicable

Completed

Conditions: Dry Mouth

Interventions: Device: Placebo
Device: Biotene

First Posted Date: 2018-09-10

Last Posted Date: 2021-01-20

Lead Sponsor: University of Rochester

Target Recruit Count: 37

Registration Number: NCT03663231

Locations: 🇺🇸
University of Rochester Eastman Dental Center, Rochester, New York, United States

Corneal Biomechanics Study

Not Applicable

Withdrawn

Conditions: Myopia

Interventions: Other: Inversion

First Posted Date: 2018-09-05

Last Posted Date: 2020-01-29

Lead Sponsor: University of Rochester

Registration Number: NCT03658239

4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy

Phase 2

Withdrawn

Conditions: Prostate Disease

Interventions: Drug: placebo
Drug: 4-aminopyridine

First Posted Date: 2018-09-05

Last Posted Date: 2018-11-02

Lead Sponsor: University of Rochester

Registration Number: NCT03658408

Locations: 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy